Maze Therapeutics targets to raise up to $133 mln in US IPO

Maze Therapeutics

27/01/2025 11:10

Jan 27 (Reuters) - Drug developer Maze Therapeutics said
on Monday it was aiming to raise as much as $132.6 million in
its initial public offering in the United States.

 (Reporting by Arasu Kannagi Basil in Bengaluru; Editing by
Vijay Kishore)
 ((ArasuKannagi.Basil@thomsonreuters.com;))